Decibel Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $63,957,000.
Profit Margin
| 2018 | 0 | -36.16M | |
|---|---|---|---|
| 2019 | 0 | -41.26M | |
| 2020 | 0 | -37.64M | |
| 2021 | 0 | -51.82M | |
| 2022 | 0 | -63.00M |
DBTX Income Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 40.33M | 29.84M | 25.32M | 29.40M | 26.16M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 63.95M | 50.23M | 39.56M | 44.08M | 37.85M |
Operating income | -63.95M | -50.23M | -39.56M | -44.08M | -37.85M |
Other income (expenses), net | 1.19M | 205K | 226K | 1.40M | 1.69M |
Income before tax | -62.76M | -50.02M | -39.33M | -42.67M | -36.16M |
Income tax expense | 240K | 1.79M | -1.69M | -1.40M | 1.69M |
Net income | -63.00M | -51.82M | -37.64M | -41.26M | -36.16M |
Earnings per share | |||||
Basic EPS | -2.52 | -2.38 | -1.63 | -5.61 | -4.98 |
Diluted EPS | -2.52 | -2.38 | -1.63 | -5.61 | -4.98 |
| Data source | Data source | Data source |